Detalhe da pesquisa
1.
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.
Blood
; 130(22): 2410-2419, 2017 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29042364
2.
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.
Sci Transl Med
; 14(631): eabg8070, 2022 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138909
3.
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.
Nat Med
; 25(7): 1064-1072, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31235963
4.
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In Vivo.
Sci Immunol
; 2(8)2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28367538
5.
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.
J Exp Med
; 213(7): 1133-9, 2016 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27242164
6.
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.
J Clin Oncol
; 34(31): 3787-3795, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269940
7.
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models.
PLoS One
; 8(6): e67256, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23825648
8.
Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.
J Virol
; 80(11): 5509-15, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16699031